Understanding the medication experience of patients with advanced non-small cell lung cancer taking epidermal growth factor receptor-tyrosine kinase inhibitors: A phenomenological study.
Meng-Jung WenHan-Lin HsuChia-Lun ChangJou-Han WangChun-Nan KuoYen-Chun HsinElizabeth H ChangPublished in: PloS one (2023)
This study also revealed medication experiences of participants' journey from seeking information in the initial phase and living with cancer, to taking back control of their own lives. Healthcare professionals could better empathize with patients' loss of control and understand their perspectives when making clinical decisions. These findings can guide interdisciplinary teams to integrate patients' beliefs and conduct pre-screening assessments of health literacy levels to tailor communication. Subsequent interventions should be developed to identify barriers to medication self-management and empower patients by building social networks.
Keyphrases
- end stage renal disease
- epidermal growth factor receptor
- advanced non small cell lung cancer
- newly diagnosed
- healthcare
- ejection fraction
- peritoneal dialysis
- chronic kidney disease
- emergency department
- mental health
- squamous cell carcinoma
- prognostic factors
- young adults
- physical activity
- tyrosine kinase
- single cell
- patient reported
- drug induced
- adverse drug